Received Mar 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | UNK | 946583 | SYR / LA |
Patient presented to hospital emergency room on Friday, February 14, 2025 and was diagnosed with GuiGuillain Barre Syndrome secondary to the FLu vaccine he had received on January 1, 2025.
N/A
N/A
N/A
N/A
Defer to patient and his medical team.